SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-007495
Filing Date
2021-06-02
Accepted
2021-06-02 08:46:32
Documents
22

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2234934
2 filename2.htm EX-1.1 254415
3 filename3.htm EX-4.19 113118
4 GRAPHIC g149028g00j65.jpg GRAPHIC 306487
5 GRAPHIC g149028g01q70.jpg GRAPHIC 65371
6 GRAPHIC g149028g05y90.jpg GRAPHIC 62964
7 GRAPHIC g149028g07r40.jpg GRAPHIC 102980
8 GRAPHIC g149028g09a44.jpg GRAPHIC 124225
9 GRAPHIC g149028g11a08.jpg GRAPHIC 125676
10 GRAPHIC g149028g12h60.jpg GRAPHIC 44245
11 GRAPHIC g149028g14g50.jpg GRAPHIC 103547
12 GRAPHIC g149028g16u40.jpg GRAPHIC 77897
13 GRAPHIC g149028g18k30.jpg GRAPHIC 89594
14 GRAPHIC g149028g20n10.jpg GRAPHIC 123322
15 GRAPHIC g149028g22x10.jpg GRAPHIC 45297
16 GRAPHIC g149028g24b20.jpg GRAPHIC 55541
17 GRAPHIC g149028g26j77.jpg GRAPHIC 144082
18 GRAPHIC g149028g28m05.jpg GRAPHIC 240681
19 GRAPHIC g149028g30u41.jpg GRAPHIC 201359
20 GRAPHIC g149028g69h88.jpg GRAPHIC 107270
21 GRAPHIC g149028g73m62.jpg GRAPHIC 49454
22 GRAPHIC g149028g93y95.jpg GRAPHIC 134731
  Complete submission text file 0000950123-21-007495.txt   5548180
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04957 | Film No.: 21987789
SIC: 2836 Biological Products, (No Diagnostic Substances)